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Disease preventionAbstract Dietary phenolic compounds (PCs) have been receiving interest for their presumed roles in
disease prevention. However, there is a lack of studies on the underlying molecular mechanisms. In
this regard, in vitro metabolomic approaches are suitable for the investigation of the molecular
changes in response to PC exposure. Up to date, the biological effects of PCs have only been exam-
ined for PCs from rosemary (Rosmarinus officinalis), olive oil, and resveratrol using cell-based meta-
bolomic approach, although transcriptomic and/or proteomic studies have also been conducted in
the same in vitro cell experiment in some cases. Our integral analysis of the reviewed studies suggest
that PCs may be involved not only in basic cellular processes or macro- and micro-nutrient meta-
bolism, but also in specific metabolic pathways that have been thoroughly investigated. These mod-
ulated pathways could have a clinical impact on neurodegenerative diseases, type 2 diabetes, cancer,
and cardiovascular diseases. In conclusion, the in vitro metabolomic approaches provide additional
information of the molecular mechanisms involved in disease risk reduction of dietary PCs. In order
to elucidate the mechanisms of action of PCs, more metabolomic cell-based studies are needed and
testing the physiological conjugated forms of PCs in these cell systems could be of special interest.nces and
nds: An
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Phenolic compounds (PCs) are characterized by a chemical
structure of hydroxylated aromatic ring(s). They are ubiqui-
tously present in plants as secondary metabolites [1] and repre-
sent the most quantitative phytochemicals supplied by the diet
[2]. So far,8000 PCs have been identified, which can be clas-
sified into different subclasses according to the number of aro-
matic rings in their structure, the elements that bind the rings
with each other, and the substituents linked to the rings.
Accordingly, four main families can be identified, namely phe-
nolic acids, flavonoids, stilbenes, and lignans [3].
PC consumption is estimated at about 1564.56 mg of gallic
acid equivalent/person/day [4]. The most important nutritional
sources of PCs are fruits and vegetables, green and black tea,
red wine, coffee, cocoa, and extra virgin olive oil [5]. Likewise,
herbs, spices, nuts, and algae are potentially important sources
of PCs as well, depending on culinary habits [6]. During the
absorption and metabolism process, PCs are also subjected to
changes and their bioactivity can consequently be modified [7].
PCs have been widely examined in humans, animals, and
in vitro studies [1]. Currently, there is an increasing interest
in exploring the practical applications of PCs focusing on their
health-promoting and disease-preventing properties against
type 2 diabetes mellitus (T2DM) [8], cardiovascular diseases
(CVDs) [9], neurodegenerative diseases [10], or cancer [11].
However, mechanistic studies are still lacking.
In this context, metabolomics, transcriptomics, and pro-
teomics may contribute to elucidating the molecular targets
of PCs [12]. Each omics technology, alone or all together, is
offering the researchers the possibility of linking food with
health and diseases. The comprehensive vision to improve con-
sumer’s well-being and knowledge using and integrating
advanced omics platforms is called ‘foodomics approach’
[13]. Therefore, foodomics might provide a huge quantity of
data about the pathways which PCs could be involved in
and the information extracted could be translated to prevent,
improve the time course, or even reverse the disease progres-
sion [13].
In particular, the metabolomic approach is becoming one
of the mostly-used tools currently for investigating changes
in the metabolome of biological systems, providing informa-
tion on the small molecules in cells or tissues and defining
the metabolic signature, thus leading to enhanced understand-
ing of the disease mechanisms [14,15]. Metabolomics assesses
the final downstream products of gene transcription and is a
good reflection of the biological system operation, namely its
phenotype [16,17]. The potential applications of metabolomic
profiling techniques for evaluating bioactivity and the possible
nutraceutical properties of diverse foods and/or bioactive com-
pounds have created unprecedented opportunities.
Single PCs might have numerous molecular targets and
subsequent physiological effects, which might not be easily
addressed through classic target biomarker approach. As a
result, the conventional use of particular biomarkers as indica-
tors of health/disease must be replaced by comprehensive
metabolic profiling. For instance, the conventional approach
to studying CVD development in in vitro cellular studies is
mostly based on some specific disease molecules (inflamma-
tion, endothelial dysfunction, or thrombosis, etc.) at the
protein and/or RNA level, which only allows a partial under-Please cite this article in press as: Catala´n U´ et al, In vitro Metabolomic Approache
UpdateIn Vitro Metabolomics and Phenolic Compounds –>. Genomics Proteomicsstanding of the mechanisms of action [18]. However, in vitro
metabolomics can focus on a small number of components,
providing practical global knowledge about the metabolic
pathways that PCs are involved in [19].
Beyond the common biofluids analyzed in metabolomics
(plasma, urine, and fecal extracts), cell cultures offer the possi-
bility for studying food ingredients or bioactive compounds (as
well as new drugs or xenobiotics) in human biological materi-
als more economically. In vitro studies can also offer benefits in
terms of ethical considerations and can result in faster develop-
ment [14].
Despite that, very few comprehensive studies have been per-
formed that focus on the research of the molecular changes in
response to PC exposure. Thus, in the present update, we
aimed to integrate all the available bibliographic information
related to the changes in the endogenous metabolite profile
induced by the external stimuli of PCs based on an in vitro
metabolomic approach. To our knowledge, this is the first time
that underlying mechanisms of PCs in the disease risk reduc-
tion resulting from in vitro metabolic expression data are
discussed.
Search strategy for the bibliographic review
The bibliographic review was carried out in PubMed (http://
www.ncbi.nlm.nih.gov/pubmed) and Scopus (http://www.sco-
pus.com). The following terms were used for the search:
‘polyphenols’, ‘phenolic compounds’, ‘cells’, ‘mechanism of
action’, and ‘metabolomics’.
The search strategy flowchart is shown in Figure 1. Using
the first search strategy, we found 29 publications, including
9 in PubMed and 20 in Scopus, of which four were excluded
from PubMed search for being reviews, for not being a cell cul-
ture experiment, or for evaluating metabolomics of the tested
food compounds. Nineteen publications were excluded from
Scopus search for matching publications found in the PubMed
search, for being reviews, or for evaluating metabolomics in
human or hamster biofluids, or plants.
Using the second search strategy, we found 28 publications
(24 in PubMed and 4 in Scopus), of which 24 were excluded
from PubMed search for matching publications found in the
first search strategy, for being editorials or reviews, or for eval-
uating metabolomics on plants, mice, rats, or human samples.
Four publications were excluded from Scopus search for
matching those found using the first strategy and by PubMed
search using the second strategy, for being a review and for
conducting metabolomics in human biofluids.
Using the third search strategy, we found 23 publications (4
in PubMed and 19 in Scopus), of which three were excluded
from PubMed search for evaluating metabolomics on plants.
Nineteen publications from Scopus search were excluded for
matching publications found using the first two strategies
and by PubMed search using the third strategy, for corre-
sponding to reviews, for being a book chapter, or for evaluat-
ing metabolomics on plants and fungus.
Using the fourth search strategy, we found 8 publications (8
in PubMed and 0 in Scopus), of which eight were excluded
from PubMed search for being the same publications found
using the first three strategies, for being a review, or for eval-
uating metabolomics on plants, mice, or pigs. No publications
were found in Scopus. Finally, seven in vitro metabolomics to Investigating the Potential Biological Eﬀects of Phenolic Compounds: An
Bioinformatics (2017), http://dx.doi.org/10.1016/j.gpb.2016.12.007
Databases
Search term strategy
Polyphenols, cells, and 
metabolomics
Polyphenols, mechanism of 
action, and metabolomics
Phenolic compounds, cells, and 
metabolomics
Phenolic compounds, 
mechanism of action, and 
metabolomics
9 publications
4 excluded
5 included
20 publications
19 excluded
1 included
24 publications
24 excluded
0 included
4 publications
4 excluded
0 included
4 publications
3 excluded
1 included
19 publications
19 excluded
0 included
8 publications
8 excluded
0 included
0 publications
0 included
Search field type: article title, 
abstract, and keywords
1 2 3 4
Figure 1 Flowchart of the search strategy
Bibliographic review was carried out in PubMed and Scopus scientific databases until January 2016. The following terms were used for the
search: ‘polyphenols’, ‘phenolic compounds’, ‘cells’, ‘mechanism of action’ and ‘metabolomics’. Reviews and studies evaluating
metabolomics on plants, mice, rats or human samples were excluded and only cell-based studies were retained.
Catala´n U´. et al / In Vitro Metabolomics and Phenolic Compounds 3studies based on the effects of several PCs were selected [20–
26]. Table 1 shows the main characteristics of the selected pub-
lications. Among these, five publications provided information
regarding rosemary phenolic extract on human colon cancer
cells HT-29 [20,21,23,24] and human erythroleukemia cell lines
K-562 [22]. Valde´s et al. [20] tested the contribution of carnosic
acid, the major PC in rosemary, individually instead of using
the whole phenolic extract. The other two studies examined
the effect of a phenolic extract from virgin olive oil containing
secoiridoids, phenolic alcohols, and lignans on colon cancer
cells SW-480 and HT-29 [26], and the effect of resveratrol on
human hepatocellular carcinoma cells HepG2 [25].
PC modulation of metabolic pathways and their
association with common diseases
Information regarding the metabolic pathways supporting the
biological role of PCs has been obtained from the metabolomic
evaluation after the in vitro experiments with rosemary and
olive oil phenolics and resveratrol [20–26]. The chemical struc-
ture and food sources of the main PCs analyzed in the present
update are represented in Figure 2. Based on the reviewed stud-
ies, we concluded that the principal functions modified by
these PCs can be classified into (1) basic cellular processes,
(2) macro- and micro-nutrient metabolism, and (3) specific
metabolic pathways. The cellular processes and pathways that
were found to be modulated are listed and classified in
Figure 3.
The basic cellular processes modulated by PCs of the pre-
sent review include: organismal systems, cell proliferation
and viability, cellular development, cellular growth, cell death,Please cite this article in press as: Catala´n U´ et al, In vitro Metabolomic Approache
UpdateIn Vitro Metabolomics and Phenolic Compounds –>. Genomics Proteomicscell-cycle metabolism, cell adhesion, cell migration, cellular
movement, cell-to-cell interaction, cellular function and main-
tenance, transport of molecules, environmental and genetic
information processing, as well as energy metabolism. The
macro- and micro-nutrient metabolism modulated by PCs is
related to protein, amino acid, lipid, glycan, nucleotide, carbo-
hydrate, cofactors, and vitamins. Only the rosemary phenolic
extract but not olive oil phenolic extract and resveratrol can
modify macro- and micro-nutrient metabolism and specific
metabolic pathways (Figure 3). The specific metabolic path-
ways modulated are explained in greater detail below.
Methylglyoxal degradation
Methylglyoxal (MGO) is a highly reactive dicarbonyl com-
pound produced as a by-product of glycolysis and represents
the main precursor of advanced glycation end-products that
are related to several diseases. Normally, cells are protected
against MGO by the glyoxalase system, the main detoxifica-
tion pathway of MGO [27]. Increased levels of MGO and
glyoxalase system dysfunction have been related to several
age-related diseases, such as diabetes, CVD, cancer, and
neurological disorders [28]. There is evidence supporting that
ferulic acid and related PCs can decrease MGO induced-
cytotoxicity in reduced glutathione (GSH)-depleted rat hepa-
tocytes by exerting a radical scavenging protective mecha-
nism [29]. These findings are consistent with the reported
up-regulation of the gene encoding aldo–keto reductase fam-
ily 1 member C1 (AKR1C1) in the HT-29 colon cancer cell
line after the incubation with the phenolic diterpene carnosic
acid [20]. AKRs are known as the major enzymes implicateds to Investigating the Potential Biological Eﬀects of Phenolic Compounds: An
Bioinformatics (2017), http://dx.doi.org/10.1016/j.gpb.2016.12.007
Table 1 In vitro foodomic studies evaluating the effects of PCs reviewed in this update
Cell types PCs and tested concentration Type of omics analysis Method
Databases used for
metabolite identiﬁcation
Expression cha s Biological functions and pathways Ref.
Human colon cancer
cells: HT29
Rosemary phenolic extract
(carnosic acid: 256.0 mg/mg);
9.9 mg/ml
Transcriptomics Microarray; RT-qPCR — 281 DEGs out 341
identified genes
Methylglyoxal degradation; dopamine,
tryptophan, melatonin, noradrenaline, and
serotonin degradation; ethanol degradation;
bile acid and retinoate biosynthesis; LPS/IL-1-
mediated inhibition of RXR function;
transport of molecules; metabolism of
terpenoid; metabolism of ROS; polyamine
metabolism
[20]
Metabolomics (nontargeted) CE-MS and HILIC/
UPLC-MS
HMD, METLIN, and
KEGG
21 DEMs Glutathione metabolism; polyamine
metabolism
Rosemary phenolic extract
(carnosol: 226.4 mg/mg;
carnosic acid: 151.5 mg/mg);
10 mM (total rosemary
phenols)
Transcriptomics Microarray; RT-qPCR — 1308 DEGs Cellular development; cell death; cellular
growth and proliferation; cell cycle; glutamate
and glutathione metabolism
[21]
Proteomics MALDI-TOF/TOF-MS — 17 DEPs Cell proliferation; cell adhesion; cell migration
Rosemary phenolic extract
(carnosol: 226.4 mg/mg;
carnosic acid: 151.5 mg/mg);
10 mM (total rosemary
phenols)
Metabolomics (nontargeted) CE-MS, RP/UPLC-MS,
and HILIC/UPLC-MS
HMD, METLIN,
KEGG compound, and
PubChem
65 DEMs Glutathione metabolism; urea cycle and
metabolism of amino groups; polyamines
homeostasis; cell proliferation and viability
Rosemary phenolic extract;
10 mM
Metabolomics (nontargeted) CE-ESI-TOF MS HMD, METLIN,
KEGG compound, and
PubChem
44 metabolites ntified Glycan biosynthesis and metabolism;
organismal systems; excretory system;
neuroactive ligand-receptor interaction;
amino, carbohydrate, lipid, nucleotide,
energy, cofactor, and vitamin metabolism;
environmental and genetic information
processing
[24]
Human colon cancer
cells: SW480 and HT29
Extra virgin olive oil extract
(decarboxymethyl oleuropein
aglycon: 238.4 mg/kg); 0.01%–
0.1%
Metabolomics (nontargeted) nanoLC-ESI-TOF-MS — 20 metabolites re
identified in ce nd
culture medium
Uptake and metabolism of polyphenols; cell-
cycle metabolism
[26]
Human hepatocellular
liver carcinoma cells:
HepG2
Resveratrol; 40 mM Metabolomics (nontargeted) 1H NMR spectroscopy — 9 DEMs out o
identified meta ites
Energy metabolism: Krebs cycle [25]
Human erythroleukemia
cells: K562 and K562/R
Rosemary phenolic extract
(carnosol: 226.4 mg/mg;
carnosic acid: 151.5 mg/mg); 5,
10 mM
Transcriptomics Microarray; RT-qPCR — 289 DEGs in K 2;
387 DEGs in K 2/R
Cellular movement; cell-to-cell signaling and
interaction; free radical scavenging; cell death;
NRF2-mediated oxidative stress response;
LPS/IL-1-mediated inhibition of RXR
function; aryl hydrocarbon receptor signaling;
protein synthesis; antigen presentation;
cellular function and maintenance
[22]
Metabolomics (nontargeted) CE-MS and UPLC-MS — 121 DEMs in K 2;
105 DEMs in K 2/R
Aminoacyl-tRNA biosynthesis; glutathione
metabolism; arginine and proline metabolism;
nitrogen metabolism; glutamate metabolism;
urea cycle and metabolism of amino groups
Note: LPS, lipopolysaccharide; IL-1, interleukin-1; RXR, retinoid X receptor; CE-MS, capillary electrophoresis–mass spectrometry; HILI PLC-MS, hydrophilic-interaction ultra-performance
liquid chromatography coupled to mass spectrometry; HMD, human metabolome database; ROS, reactive oxygen species; MALDI-TOF/TOF S, matrix-assisted laser desorption/ionization-time of
flight mass spectrometry; RP, reverse phase; ESI, electrospray ionization; NMR, nuclear magnetic resonance; NRF2, nuclear factor-like. G, differentially-expressed gene; DEP, differentially-
expressed protein; DEM, differentially-expressed metabolite.
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Catala´n U´. et al / In Vitro Metabolomics and Phenolic Compounds 5in the reduction of carbonyl substrates that are involved in
the synthesis of endogenous compounds as well as xenobi-
otic detoxification, providing a protection against cellular
damage [30].
Polyamine metabolism
Polyamines such as putrescine, spermidine, and spermine can
interact with proteins, DNA, and RNA, and play various roles
in cell growth and proliferation. Variations in polyamine levels
have been related with certain diseases such as stroke, cancer,
renal failure, inflammation, or diabetes [31]. Thus, polyamine
function and metabolism is an attractive target for therapeutic
intervention, especially for antiproliferative usages [32].
Protective effects against cancer of PCs have been described
in HT-29 cells treated with carnosic acid, which are potentially
related to polyamine metabolism modulation. This metabolic
change is explained by an up-regulation of the gene encoding
monoamine oxidase type B (MAO-B) that is involved in
the enzymatic transformation of N-acetylputrescine to
4-acetamidobutanal, thus resulting in the reduced level of
N-acetylputrescine with carnosic acid treatment [20]. Similarly,
Caco-2 cells exposed to a procyanidin-enriched extract
showed a significant reduction in two key enzymes of
polyamine biosynthesis (ornithine decarboxylase and S-adeno-
sylmethionine decarboxylase), leading to a decrease in intracel-
lular polyamines [33]. These results suggest that polyamine
pathway could be an important target for PCs as anti-
proliferative agents.Please cite this article in press as: Catala´n U´ et al, In vitro Metabolomic Approache
UpdateIn Vitro Metabolomics and Phenolic Compounds –>. Genomics ProteomicsDopamine, noradrenaline, and serotonin degradation
Dopamine, noradrenaline, and serotonin are neurotransmit-
ters, and their reduction contributes to the occurrence of cog-
nitive decline and neurodegeneration [34]. Specifically, the
dopaminergic system as well as abnormal serotonin neuro-
transmission may be related with the occurrence of Alzhei-
mer’s disease (AD) [35] and Parkinson’s disease (PD) [36]. A
foodomic approach has revealed that carnosic acid induces
transcriptional regulation of several genes implicated in the
degradation of dopamine, noradrenaline, and serotonin, pro-
viding new evidence for potential signaling pathways modu-
lated by PCs [20]. In line with these observations, a potential
effect of epigallocatechin-3-gallate has been shown against
lipopolysaccharide-induced neurotoxicity through reducing
inflammatory mediators’ tumor necrosis factor-alpha and
nitric oxide and maintaining dopamine levels in midbrain [37].
Another canonical pathway implicated in neurotransmitter
metabolism and revealed to be regulated by rosemary pheno-
lics in this update is the tryptophan depletion [20], which has
been shown to take part in the development of AD, PD, and
Huntington’s disease (HD) [38]. Recent findings have also
shown that PCs can inhibit tryptophan breakdown in periph-
eral blood mononuclear cells [39].
Melatonin degradation
A relationship has been established between melatonin and
aging, neurodegeneration [40], T2DM [41], autism [42], as wells to Investigating the Potential Biological Eﬀects of Phenolic Compounds: An
Bioinformatics (2017), http://dx.doi.org/10.1016/j.gpb.2016.12.007
Figure 3 Metabolic pathways modiﬁed by the phenolic compounds reviewed in this updateAll the metabolic pathways shown in the figure
are modified by rosemary phenolic extract. The increase and decrease in the biological functions are indicated with arrows " and ;,
respectively. Biological functions without arrows indicate that the increase or decrease of these functions is not specified in the original
articles.
6 Genomics Proteomics Bioinformatics xxx (2017) xxx–xxxas bone status [43]. This pineal hormone has atheroprotective
effects [44] and is able to behave as a ‘smart killer’ by modulat-
ing apoptosis processes in cancer cells and promoting survival
in non-tumor cells [45]. This update shows for first time the
association between polyphenols and melatonin degradation
pathway at the gene level, after the in vitro exposure of cells
to rosemary phenolics [20].
Ethanol degradation
It has been reported that heavy or binge alcohol intake
increases the risk of all-cause mortality, whereas moderate
consumption, especially of wine and beer, might have cardio-
protective effects [46]. A foodomic study has revealed that,
enzymes related to ethanol degradation pathway were posi-
tively modulated in HT-29 cells after treatment with carnosic
acid. In particular, the up-regulation of the gene encoding
aldehyde dehydrogenases 3A1 (ALDH3A1) could also
counteract the formation of aldehydes produced by
monoamine oxidases [20]. In line with this study, catechins
from black tea partially prevent alterations of oxidative
parameters induced by ethanol in old rats [47]. These findings
suggest a beneficial effect of PCs on the ethanol degradation
pathway.
Terpenoid metabolism
Terpenoids (also called isoprenoids) and particularly retinoic
acid, have been shown to down-regulate proliferation markersPlease cite this article in press as: Catala´n U´ et al, In vitro Metabolomic Approache
UpdateIn Vitro Metabolomics and Phenolic Compounds –>. Genomics Proteomicsand to inhibit tumor growth, angiogenesis, and metastasis [48].
Additionally, direct actions of retinoids have been reported in
insulin secretion through pancreatic b-cell function [49], and
the maintenance of immunity, reproduction, and embryonic
development [50]. Early work has also shown that the level
of long-chain isoprenoid dolichol is decreased, whereas the
level of dolichyl phosphate and ubiquinone is increased in
brains of AD patients [51]. Moreover, as the important regula-
tors of macrophages [52], retinoid X receptors (RXR) might
inhibit the initial inflammatory process preceding the atheroge-
nesis [53]. Pathway analysis indicates that the metabolism of
terpenoid pathway could be significantly repressed in HT-29
cells treated with carnosic acid by the reduced expression of
genes encoding alcohol dehydrogenase 1C (ADH1C), endothe-
lin 1 (EDN1), nuclear receptor subfamily 4 group A member 1
(NR4A1), and prolactin receptor (PRLR) [20], suggesting an
anticancer protective effect of carnosic acid. Along the same
line, a cancer prevention effect has been reported after a long
term consumption of a green tea phenolic extract in rats with
induced colon carcinoma, due to the increased levels of RXRa
[54].
GSH metabolism
GSH is considered to be one of the most important scavengers
of reactive oxygen species (ROS), which has been involved in
the progression of a number of aging diseases, such as cancer,
CVD, and neurodegenerative diseases [55]. GSH depletion hass to Investigating the Potential Biological Eﬀects of Phenolic Compounds: An
Bioinformatics (2017), http://dx.doi.org/10.1016/j.gpb.2016.12.007
Catala´n U´. et al / In Vitro Metabolomics and Phenolic Compounds 7been described as a common process of apoptotic cell death
initiated by various stimuli [56]. Thus, GSH modulation has
been thoroughly investigated for potential anticancer
treatments.
Several metabolomic studies in leukemia and colon cancer
cell lines have demonstrated that rosemary phenolics increase
GSH levels with a rise of the GSH/glutathione disulfide
(GSSG) ratio [20,22]. Combined with the transcriptomic data,
functional analysis underscored an activation of ROS metabo-
lism and expression modification of several genes related to
oxidative degradation pathways in both cell lines. These results
suggested that rosemary phenolics could enhance the detoxify-
ing cellular capabilities, which is necessary for cancer growth
inhibition. It has also been suggested that PCs modify intracel-
lular GSH concentrations through modulating detoxification
processes and protein glutathionylation, as well as adjusting
the redox switching of protein functions [57].
Aminoacyl-tRNA biosynthesis
Aminoacyl-tRNA synthetases (ARSs) are essential for the first
step in protein synthesis. It has been reported that defects in
ARS functions may contribute to several diseases such as can-
cer [58]. A metabolomic approach for leukemia cells treated
with rosemary PCs showed an increased expression of the gene
encoding valyl-tRNA synthetase (VARS), which is related to
aminoacyl-tRNA biosynthesis pathway. In addition, the
authors also detected changes in the amount of related
metabolites, in particular some amino acids such as Met,
Leu, Glu, Tyr, Lys, and Phe [22]. Along the same line, an
increase in aminoacyl-tRNA content in osteoblastic MC3T3-
E1 cells was observed due to the action of the isoflavone genis-
tein, which is involved in the activation of ARSs [59].
Aryl hydrocarbon receptor signaling
The activation of aryl hydrocarbon receptor (AhR) has been
shown to reduce immune responses, leading to suppression
of autoimmune diseases [60], and possibly reduce inflamma-
tion associated with Crohn’s disease as well [61]. An abnormal
AhR function has also been associated with cancer [62]. The
AhR signaling, which is associated with the transcription of
genes encoding metabolizing enzymes and antioxidant pro-
teins, was enhanced in leukemia cells in response to rosemary
PCs [22]. To screen for natural AhR agonists in foods,
Amakura et al. assessed multiple food materials and found
that cassia seed and rosemary extracts exhibited high AhR
activity [63].
Bile acid biosynthesis
Beside the well-established role of bile acids in cholesterol
homeostasis and lipid absorption, Kuipers et al. have also
demonstrated glucose-lowering actions of bile acids in
insulin-resistant states and T2DM [64]. Additionally, high con-
centrations of deoxycholic acid have been shown to induce cell
proliferation, causing hyperproliferation in the colorectal
mucosa, which is an early stage in colorectal cancer [65].
Administration of 0.5% apple phenolic extract in rats leads
to an up-regulation of the expression of farnesoid X receptor
that takes part in the bile acid biosynthesis and consequentlyPlease cite this article in press as: Catala´n U´ et al, In vitro Metabolomic Approache
UpdateIn Vitro Metabolomics and Phenolic Compounds –>. Genomics Proteomicsimproved blood cholesterol levels [66]. Investigation on colon
cancer HT-29 cells treated with carnosic acid has revealed that
the phenolic carnosic acid from rosemary can modulate the
biological process of bile acid biosynthesis [20].
Translational perspective of PCs in disease
prevention
After in-depth examination of the pathways modulated by the
PCs studied, the next step is to analyze the illnesses and disor-
ders involving these pathways. Based on the integrated data, it
seems that the PCs could have an essential role mainly in the
prevention of neurodegenerative disorders, T2DM, cancer,
and CVD (Table 2). In particular, carnosic acid and carnosol,
the main PCs present in rosemary, appear to be implicated in
most of the metabolic pathways analyzed in Table 2.
Resveratrol is mainly involved in energy metabolism regu-
lated by a peroxisome proliferator-activated receptor [67,68],
and this pathway has been related to the nervous system, can-
cer, diabetes, and neurodegenerative disorders, such as AD
[69,70]. Extra virgin olive oil phenolic extract is mostly associ-
ated with cell-cycle metabolism. Dysregulation of this process
has been related with the etiology of major chronic pathologies
such as cancer, atherosclerosis, inflammation, and neurodegen-
erative disorders such as AD, HD, and PD [71].
Plant-derived food, such as fruits, vegetables, aromatic
herbs or olive oil, contains a diverse group of PCs with many
potential disease prevention effects. Occidentals consume more
than 1 g/day of PCs and even close to 3 g/day if fiber-bound
PCs are taken into account [72]. However, only less than 5%
is directly absorbed and metabolized by the body [72]. Once
absorbed, PCs are extensively altered during first-pass metabo-
lism so that, typically, the molecular forms reaching the
peripheral circulation and tissues are different from those pre-
sent in foods. The resulting metabolites have different molecu-
lar structures (mainly sulphated and glucuronidated forms of
the parent aglycone) and consequently their biological activi-
ties in the target organs can differ.So, under physiological sit-
uation, plasma and tissues are not exposed to PCs in the
aglycone forms [73]. Therefore, future metabolomic cell-
based studies should be performed to test the conjugated forms
of PCs found in plasma with the concentration range of 0.1–
10 lM, the maximum plasma concentrations detected after
normal consumption of PC-rich foods [73]. Thus, human data
concerning bioavailability and metabolism of PCs are of great
value for future studies focusing on defining biological activi-
ties of PCs.
Despite the promising role of PCs in the improvement of
cellular functions and pathways, evidence is not strong enough
to suggest the optimal intake doses. The underlying mecha-
nisms of PCs in chronic disease prevention are still poorly
understood. Therefore, the recommendation is to eat a variety
of vegetables, fruits, and other plant-derived food containing
different types of PCs, which presumably provides the best
protection.
Future developments
The metabolic data available up till now offer promising
knowledge about the role of dietary PCs in preventing and/s to Investigating the Potential Biological Eﬀects of Phenolic Compounds: An
Bioinformatics (2017), http://dx.doi.org/10.1016/j.gpb.2016.12.007
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of several metabolic pathways. Thus, metabolomic profiling
techniques used in cell-based studies provide unprecedented
opportunities to evaluate the mechanisms-of-action for PCs,
with complementary data of human studies. Metabolomic data
also provide a more realistic understanding of the role of PCs
in disease recognition/prevention. According to Lee [74], the
in vitro metabolomic model can be employed to fully elucidate
whether the in vivo observations actually have molecular basis.
In conclusion, assessing the biological effects of specific PCs
by in vitro metabolomic approaches has contributed to better
definition of a metabolomic signature and enhanced under-
standing of disease mechanisms in response to PCs exposure.
Moreover, the reviewed metabolomic data have provided the
possible clinical impact of PCs on common diseases, conclud-
ing that PCs are mainly implicated in neurodegenerative dis-
eases, T2DM, cancer, and CVDs. Despite its analytical
capacity, the utilization of metabolomic approach in the study
of disease prevention by PCs is still in its infancy. Therefore,
new and more refined metabolomic approaches testing other
types of PCs are needed to finally elucidate the underlying
mechanisms of specific PCs in human physiological and patho-
logical processes.
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